NJ High Court OKs Roche's Bids To Review Accutane Rulings

Law360, Clifton, N.J. (December 8, 2017, 8:22 PM EST) -- Hoffmann-La Roche Ltd. has convinced the New Jersey Supreme Court to review two state appellate decisions related to the company's acne medication Accutane, with the justices agreeing to consider rulings over the adequacy of the drug's label and the admissibility of expert testimony.

In orders made available Friday, the state's highest court granted separate petitions for certification filed by the pharmaceutical giant in challenging appellate opinions, issued three days apart in July, that upended trial court victories for the company in multicounty litigation over Accutane....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.